Clinical Trial Update: To Evaluate the Efficacy and Safety of JW0201 Added on in Patients With Type 2 Diabetes Mellitus [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating JW0201 for type 2 diabetes mellitus has completed; no efficacy or safety results are provided in the snippet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• JW0201

Snippet

Sponsor: JW Pharmaceutical | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED